CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019

16% Increase in Quarter-over-Quarter Revenue; Quarterly Expense Reduction of 17% TORONTO, May 30, 2019 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“CB2” or the “Company”), a leading technology company focused on mainstreaming medical cannabis to the healthcare industry through Real World Evidence (“RWE”), today reported its results for the first quarter of 2019. Additional information […]

READ MORE: https://www.newcannabisventures.com/cb2-insights-posts-strong-growth-in-clinical-revenue-and-drives-operating-efficiencies-in-q1-2019/